Linical Co., Ltd. (2183.T)
Tokyo · JPY · Healthcare · Biotechnology
¥200 (-0.50%) as of
Key statistics
- Market cap
- 4.52B
- Forward P/E
- 8.51
- EPS (TTM)
- -167.75
- Dividend yield
- 3.98%
- 52-week range
- 198.00 – 353.00
- Beta
- 0.38
- Revenue (TTM)
- 7.95B
- Profit margin
- -47.64%
- Volume
- 13.80k
About Linical Co., Ltd.
Linical Co., Ltd., a global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug discovery consulting services, such as market analysis and research of products in development, regulatory affairs, and licensing support. It also provides clinical trial evaluation, statistical analysis, medical writing, pharmacovigilance, clinical monitoring, and contract medical affairs services. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Osaka, Japan
- Employees
- 577
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.